Bonuses return for United Drug executives last year

TOTAL remuneration levels for executive directors at Irish healthcare services group United Drug rose last year, as bonus payments made a return on the back of an increase in the company’s financial performance.

The drug wholesale and multi-disciplined healthcare services provider saw both full-year revenue and pre-tax profits grow by 1% in the 12 months to the end of last September.

While the dividend payment to shareholders rose by 40 cent, on a year-on-year basis, so too did the overall remuneration outlay to the group’s executive director team — going from just under €2.83 million in 2009 to €3.42m last year.